FdaApplication
ANDA 209225
Identifiers
- fda_app_no: ANDA209225
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2023-03-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE | 75MG;25MG | CAPSULE;ORAL |
1 product